OTC Momentum Watchlist (RDARD, TSOI, MSXG, KEGS, FONU)

With the first week of trading in 2023 finished up, it’s time to look forward to the upcoming week to see if the market will rally behind a strong first week push.

Trading in OTC stocks picked up, most notably in the sub penny area. Investors that are looking to book profits early in 2023, may want to pay attention to a number of stocks under a penny that rallied last week.

Here are a few standouts that belong on everyone’s radar.

Raadr Inc. (OTC: RDARD) – This software company publishes applications that protect children who use social media and the internet. RAADR’s products allow children, parents, school districts, and law enforcement to monitor bullying and other threatening behavior across social media and the metaverse in real time.

RAADR Parental 2.0, the company’s parental monitoring and student reporting social media app, allows parents to protect children by using real time monitoring across all major social media platforms, as well as the metaverse, to report cyberbullying, suicidal thoughts, and threatening behavior.

The application features multiple different tools to enhance anti-bullying efforts, including image recognition, keyword recognition, site filtering, and the ability to monitor children across multiple social media platforms found across the internet. All of these features are also offered in real-time alerts to users.

In a recent letter to shareholders, company CEO Jacob DiMartino stated, “Over the past 6 months, we have worked diligently with Cooperative Computing, our new development team, to complete final development and beta testing.” “We anticipate completion within the next few weeks, and shortly thereafter, we will submit the app for inclusion on both the Google Play and Apple App stores.”

Friday’s trading session ended favorably for the company, with shares finishing up 25%.

Therapeutic Solutions International Inc. (OTC: TSOI) – Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases.

Last week, the company announced a patent filing that disclosed proprietary methods for the use of a tattoo gun, or a similar device, to administer a compound that induces a tolerogenic microenvironment, followed by the administration of the antigen in the artificially created microenvironment for antigen specific suppression of immunity.

The company’s CEO said, “While we are highly focused on execution of our Phase III COVID clinical trial, through our multiple collaborations, we discover multiple unexpected findings on a regular basis.” “The advantage of possessing a patent portfolio of 70 issued and pending patents is that our shareholders may benefit not only from successes of products we develop but also from licensing fees in a diverse area of biotechnology.”

The stock finished up Friday 53.06% up at a share price of $.0026. With such a strong first week performance, investors should pay close attention in the upcoming trading week.

Mexus Gold US (OTC: MXSG) – Mexus Gold US is an American mining company with multiple operations across Mexico. Mexus also owns rights to the site known as the Ures Property which is located 80 kilometers north of Hermosillo, Mexico. Notably, this property contains 6900 acres and has both gold and copper on the property.

In a year end update, Mexus President, Paul Thompson Sr., addressed shareholders on the company’s 2023 plans to actively pursue JV partnerships, stating, “I believe the company has found the right partner to further this goal.” “I am excited about this potential agreement and hope to make an announcement in early 2023.”

The stock had a strong first week of 2023, finishing up 75% on Friday, making this a stock to watch in the upcoming week.

1812 BREWING COMPANY, INC. (OTC:KEGS) – This company is an operator of and investor in companies in the craft beer industry. The Company’s current holding, 1812 Brewing Co., produces award-winning craft beers of various styles, available for both in-house consumption, and distribution.

Recently, KEGS announced that Chairman and CEO Tom Scozzafava exchanged his shares of common stock for a company note. 3.4 billion shares of common stock were returned to the transfer agent and taken back into the company’s treasury. The transaction, which became effective December 28, 2022, and resulted in a decrease of outstanding shares by 3.4 billion.

On the back of this news, the stock finished up 31% on Friday, and traded at a 6 month high of .0013 cents per share.

FONU2 Inc. (OTC: FONU) – FONU2 is a holding company in the process of restructuring its business model to become fully reporting and uplist to a national exchange with a focus on acquiring and restructuring undervalued real estate assets.

While there is no news out currently, the stock was very active last week, trading well above its typical volume averages. Investors appear to be loading up at these low levels, looking for a run in 2023.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, assumptions of future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. RazorPitch is responsible for the production and distribution of this content. RazorPitch is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. RazorPitch authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. RazorPitch has been compensated by Lightwave Partners to produce and syndicate this content for RDARD. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website.